Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0HXP
|
||||
| Drug Name |
N-(2-Diethylamino-ethyl)-3-(5-sulfamoyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-benzamide
|
||||
| Synonyms |
CHEMBL100329
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C15H22N6O5S3
|
||||
| Canonical SMILES |
CCN(CC)CCNC(=O)c1cccc(c1)S(=O)(=O)Nc2nnc(s2)S(=O)(=O)N
|
||||
| InChI |
InChI=1S/C15H22N6O5S3/c1-3-21(4-2)9-8-17-13(22)11-6-5-7-12(10-11)29(25,26)20-14-18-19-15(27-14)28(16,23)24/h5-7,10H,3-4,8-9H2,1-2H3,(H,17,22)(H,18,20)(H2,16,23,24)
|
||||
| InChIKey |
MLZAWUZXMPRAMY-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Carbonic anhydrase II | Target Info | [1587926] | ||
| Carbonic anhydrase I | Target Info | [1587926] | |||
| NetPath Pathway | IL4 Signaling Pathway | ||||
| EGFR1 Signaling Pathway | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| PathWhiz Pathway | Gastric Acid Production | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.